肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

人类癌症中epi- mirna对DNA甲基化机制的调控:癌症治疗中出现的新靶点

Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy 

原文发布日期:2020-08-10 

英文摘要:

摘要翻译: 

原文链接:

文章:

人类癌症中epi- mirna对DNA甲基化机制的调控:癌症治疗中出现的新靶点

Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy 

原文发布日期:2020-08-10 

英文摘要:

Disruption in DNA methylation processes can lead to alteration in gene expression and function that would ultimately result in malignant transformation. In this way, studies have shown that, in cancers, methylation-associated silencing inactivates tumor suppressor genes, as effectively as mutations. DNA methylation machinery is composed of several genes, including those with DNA methyltransferases activity, proteins that bind to methylated cytosine in the promoter region, and enzymes with demethylase activity. Based on a prominent body of evidence, DNA methylation machinery could be regulated by microRNAs (miRNAs) called epi-miRNAs. Numerous studies demonstrated that dysregulation in DNA methylation regulators like upstream epi-miRNAs is indispensable for carcinogenesis; consequently, the malignant capacity of these cells could be reversed by restoring of this regulatory system in cancer. Conceivably, recognition of these epi-miRNAs in cancer cells could not only reveal novel molecular entities in carcinogenesis, but also render promising targets for cancer therapy. In this review, at first, we have an overview of the methylation alteration in cancers, and the effect of this phenomenon in miRNAs expression and after that, we conduct an in-depth discussion about the regulation of DNA methylation regulators by epi-miRNAs in cancer cells. 

摘要翻译: 

DNA甲基化过程的紊乱可导致基因表达和功能的改变,最终引发恶性转化。研究表明,在癌症中,甲基化相关沉默使抑癌基因失活的效应与基因突变相当。DNA甲基化机制由多个基因构成,包括具有DNA甲基转移酶活性的基因、启动子区域结合甲基化胞嘧啶的蛋白质以及具有去甲基化酶活性的酶类。大量证据表明,DNA甲基化机制可受被称为表观miRNA(epi-miRNAs)的微小RNA调控。众多研究证实,DNA甲基化调节因子(如上epi-miRNAs)的失调在致癌过程中起关键作用;因此,通过恢复癌症中这种调控系统,可逆转细胞的恶性转化能力。可以预见的是,对癌细胞中这些epi-miRNAs的识别不仅能够揭示致癌过程中的新分子实体,还有望为癌症治疗提供新的靶点。本文首先概述癌症中甲基化改变及其对miRNAs表达的影响,随后深入探讨癌细胞中epi-miRNAs对DNA甲基化调节因子的调控作用。

原文链接:

Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy 

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……